Intrinsic Value of S&P & Nasdaq Contact Us

Arcellx, Inc. ACLX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
32/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$110.42
-3.9%

Stock Statistics — ACLX

Arcellx, Inc. (ACLX) has a market capitalization of $6.72B and trades at $114.89. The 52-week range is 47.86-114.94.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -28.2, Earnings Per Share (EPS) of $-4.07, annual revenue of $22.29M.

The stock has a beta of 0.25, operates in the Healthcare sector.

Trading Data
Current Price$114.89
52-Week Range47.86-114.94
Volume539.58K
Avg Volume (30D)2.25M
Market Cap$6.72B
Beta (1Y)0.25
Company
IPO Date2022-02-04
Employees163
CEORami Elghandour
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS03940C1009
CUSIP03940C100
Income (Latest Year)
Revenue$22.29M
Gross Profit$15.61M
EBITDA$-197.97M
Operating Income$-253.08M
Net Income$-228.93M
EPS$-4.07
EPS Diluted$-4.07
Shares Outstanding$56.31M
Balance Sheet (Latest Year)
Total Assets$603.99M
Current Assets$462.18M
Cash & ST Investments$450.33M
Total Liabilities$201.64M
Total Debt$96.26M
Net Debt$16M
Total Equity$402.35M
Debt / Equity0.24
Valuation Ratios
P/E Ratio-28.2
P/S Ratio301.48
P/B Ratio16.7
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message